Dr Lu-jean M Feng, MD in Pepper Pike, OH - Plastic Surgery

Dr Lu-jean M Feng, MD is a Plastic Surgery physician based in Pepper Pike, Ohio. Dr Lu-jean M Feng is licensed to practice in Ohio (license number 35-05-5358F) and her current practice location is 31200 Pinetree Road, Pepper Pike, Ohio. She can be reached at her office (for appointments etc.) via phone at (216) 831-7007.

NPI number for Dr Lu-jean M Feng is 1942387824 and her current mailing address is 31200 Pinetree Rd, Pepper Pike, Ohio. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1942387824.

Contact Information

	Dr Lu-jean M Feng, MD
	31200 Pinetree Road, Pepper Pike, OH 44124-5928
	(216) 831-7007
	Not Available

Physician's Profile

Full Name	Dr Lu-jean M Feng
Gender	Female
Speciality	Plastic Surgery
Location	31200 Pinetree Road, Pepper Pike, Ohio
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1942387824
Provider Enumeration Date: 10/31/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Lu-jean M Feng such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1942387824	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208200000X	Plastic Surgery	35-05-5358F (Ohio)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Lu-jean M Feng is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Lu-jean M Feng, MD 31200 Pinetree Rd, Pepper Pike, OH 44124-5928 Ph: (216) 831-7007	Dr Lu-jean M Feng, MD 31200 Pinetree Road, Pepper Pike, OH 44124-5928 Ph: (216) 831-7007

News Archive

TD2 and COTI work together to obtain approval of clinical trials for COTI-2

TGen Drug Development (TD2) and Critical Outcome Technologies Inc. (COTI) (TSXV:COT) announced today that they will work together to obtain approval of clinical trials for a promising new anti-cancer drug called COTI-2.

First Spouses support Down syndrome cognitive research

New Jersey Governor First Spouse Mary Pat Christie was joined by several other First Spouses from across the country in sponsoring the "Light the Way" event on March 21, 2011 to increase awareness of, and encourage support for, the rapidly advancing area of Down syndrome cognitive research.

Natural killer cell response detrimental to glioblastoma virotherapy

For the first time, researchers have demonstrated that the response of natural killer (NK) cells is detrimental to glioblastoma virotherapy, a novel way of treating malignant brain cancer by injecting a virus into the tumor.

Healthy food programs in grocery stores may help reduce diet-related illnesses

Bringing healthy food programs to corner grocery stores in the inner city might be a step toward improving residents' diet and reducing diet-related illnesses, a new study suggests.

Dr Lu-jean M Feng, MD - Plastic Surgery in Pepper Pike, OH